Krystal Biotech's (KRYS) Vyjuvek approval is "best case scenario" - PT Raised to $130 at TD Cowen
Tweet Send to a Friend
(Updated - May 22, 2023 7:33 AM EDT)
TD Cowen analyst Ritu Baral raised the price target on Krystal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Ritu Baral raised the price target on Krystal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
